Columvi (glofitamab)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Columvi (glofitamab), covering 2025-03-18 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma [Phase 2]